279 related articles for article (PubMed ID: 23200965)
1. Determinants of urolithiasis in patients with intestinal fat malabsorption.
Siener R; Petzold J; Bitterlich N; Alteheld B; Metzner C
Urology; 2013 Jan; 81(1):17-24. PubMed ID: 23200965
[TBL] [Abstract][Full Text] [Related]
2. Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis.
Siener R; Machaka I; Alteheld B; Bitterlich N; Metzner C
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33053816
[TBL] [Abstract][Full Text] [Related]
3. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
4. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
Hamid R; Robertson WG; Woodhouse CR
BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
[TBL] [Abstract][Full Text] [Related]
6. The effect of restrictive bariatric surgery on urinary stone risk factors.
Semins MJ; Asplin JR; Steele K; Assimos DG; Lingeman JE; Donahue S; Magnuson T; Schweitzer M; Matlaga BR
Urology; 2010 Oct; 76(4):826-9. PubMed ID: 20381135
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
[TBL] [Abstract][Full Text] [Related]
8. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
9. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Leavitt DA; Moeding A; Stessman M; Monga M
Urology; 2012 Feb; 79(2):282-6. PubMed ID: 22000931
[TBL] [Abstract][Full Text] [Related]
11. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
[TBL] [Abstract][Full Text] [Related]
12. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
[TBL] [Abstract][Full Text] [Related]
13. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
Lindsjö M
Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
[TBL] [Abstract][Full Text] [Related]
14. Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants.
Ciacci C; Spagnuolo G; Tortora R; Bucci C; Franzese D; Zingone F; Cirillo M
J Urol; 2008 Sep; 180(3):974-9. PubMed ID: 18639267
[TBL] [Abstract][Full Text] [Related]
15. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
Siener R; Ebert D; Nicolay C; Hesse A
Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
[TBL] [Abstract][Full Text] [Related]
17. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
Strohmaier WL; Seilnacht J; Schubert G
Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
[TBL] [Abstract][Full Text] [Related]
18. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
19. Urine calcium/citrate ratio in children with hypercalciuric stones.
Srivastava T; Winston MJ; Auron A; Alon US
Pediatr Res; 2009 Jul; 66(1):85-90. PubMed ID: 19287339
[TBL] [Abstract][Full Text] [Related]
20. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
